The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
Open accessAbstract
Genome editing with targeted nucleases and DNA donor templates homologous to the break site has proven challenging in human hematopoietic stem and progenitor cells (HSPCs), and particularly in the most primitive, long-term repopulating cell population. Here we report that combining electroporation of zinc finger nuclease (ZFN) mRNA with donor template delivery by adeno-associated virus (AAV) serotype 6 vectors directs efficient genome editing in HSPCs, achieving site-specific insertion of a GFP cassette at the CCR5 and AAVS1 loci in mobilized peripheral blood CD34+ HSPCs at mean frequencies of 17% and 26%, respectively, and in fetal liver HSPCs at 19% and 43%, respectively. Notably, this approach modified the CD34+CD133+CD90+ cell population, a minor component of CD34+ cells that contains long-term repopulating hematopoietic stem cells (HSCs). Genome-edited HSPCs also engrafted in immune-deficient mice long-term, confirming that HSCs are targeted by this approach. Our results provide a strategy for more robust application of genome-editing technologies in HSPCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AAV6 homologous donor DNA templates are an efficient way to deliver donor templates for sensitive primary immune cells, including HSPCs and T-Cells15,35–40.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [35]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Héry-Arnaud, G., Berre, R. L., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 5,008
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Gaj, T., Gersbach, C. A., & Barbas, C. F. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.04.004 · Cited by 3,820
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
Self-citationInsertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35700 · Cited by 1,854
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Tebas, P., Stein, D., Tang, W. W., Frank, I., Wang, S. Q., Lee, G., Spratt, S. K., Surosky, R. T., Giedlin, M. A., Nichol, G., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300662 · Cited by 1,357
Self-citationRegulation of DNA repair throughout the cell cycle
Branzei, D., & Foiani, M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2351 · Cited by 1,228
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–261 of 261
Radtke, S., Colonna, L., Perez, A. M., Hoffman, M., Kean, L. S., & Kiem, H. (2020) · Transplantation Direct · doi:10.1097/txd.0000000000001029 · Cited by 8
Moço, P. D., Farnós, O., Sharon, D. M., & Kamen, A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100486 · Cited by 8
Gene therapy strategies for RAG1 deficiency: Challenges and breakthroughs
Gilioli, G., Lankester, A. C., de Kivit, S., Staal, F. J. T., & de Bruin, L. M. O. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106931 · Cited by 8
Emerging cellular and gene therapies for congenital anemias
Ludwig, L. S., Khajuria, R. K., & Sankaran, V. G. (2016) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31529 · Cited by 9
Zheng, Q., Zhang, X., Yang, H., Xie, J., Xie, Y., Chen, J., Yu, C., & Chen, Z. (2019) · Viruses · doi:10.3390/v11100920 · Cited by 8
Gutiérrez-Guerrero, A., Perian, S., Leray, A., Martinello, C., Abrey-Recalde, M. J., Costa, C., Herrero, C. I., Bouzelha, M., Álvarez‐Dorta, D., Gouin, S. G., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102495 · Cited by 7
Non-clinical safety considerations on genome editing using the CRISPR/Cas system
Toofan, P., Singh, M., Brööks, A. G., & McLuckie, K. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101785 · Cited by 6
Ahmed, A., Molfetta, D. D., Iaconisi, G. N., Caponio, A., Singh, A., Bibi, A., Dolce, V., Palmieri, L., Coppola, V., & Fiermonte, G. (2026) · Cells · doi:10.3390/cells15010081 · Cited by 10
Genome- and cell-based strategies in therapy of muscular dystrophies
Saada, Y. B., Dib, C., Lipinski, M., & Vassetzky, Y. S. (2016) · Biochemistry (Moscow) · doi:10.1134/s000629791607004x · Cited by 7
Dolatshad, H., Tatwavedi, D., Ahmed, D., Tegethoff, J. F., Boultwood, J., & Pellagatti, A. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.10.001 · Cited by 7
TALEN mediated gene editing in a mouse model of Fanconi anemia
Pino-Barrio, M. J., Gimenez, Y. A., Villanueva, M., Hildenbeutel, M., Sánchez‐Domínguez, R., Rodríguez, S., Pujol, R. M., Surrallés, J., Rı́o, P., Cathomen, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63971-z · Cited by 7
Chen, Z., Yu, Q., Jia, W., Yu, X. Y., Yu, D., Yang, M., Wang, L., Ling, C., & Zhu, L. (2020) · The FASEB Journal · doi:10.1096/fj.201902875r · Cited by 6
The effect of histone deacetylase inhibitors on the efficiency of the CRISPR/Cas9 system
Bjornson, Y. M., Huang, C. Y., Rollins, J. L., Castañeda, G. A. L., Kaur, N., Yamamoto, E., & Johnston, J. M. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101513 · Cited by 7
CRISPR-based precision medicine for hematologic disorders: Advancements, challenges, and prospects
Sahu, S., Poplawska, M., Lim, S. H., & Dutta, D. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122165 · Cited by 9
Pharmacodynamics of anti-HIV gene therapy using viral vectors and targeted endonucleases
Roychoudhury, P., Feelixge, H. S. D. S., Pietz, H. L., Stone, D., Jerome, K. R., & Schiffer, J. T. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw104 · Cited by 6
Recent Advances in Therapeutic Genome Editing in China
Yang, Y., Wang, Q., Li, Q., Men, K., He, Z., Deng, H., Ji, W., & Wei, Y. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.210 · Cited by 6
Chattong, S., Chaikomon, K., Chaiya, T., Tangkosakul, T., Palavutitotai, N., Anusornvongchai, T., & Manotham, K. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0007 · Cited by 7
Canarutto, D., Fiumara, M., Venkatesan, V., Gaddoni, C., Shiroshita, K., Varesi, A., Albano, L., Pelosi, G., Silva, A., Firrito, C., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03142-z · Cited by 5
Prenatal Gene Therapy for Metabolic Disorders
Coons, B. E., & Peranteau, W. H. (2021) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000662 · Cited by 5
Peterson, C. W., Venkataraman, R., Reddy, S. S., Pande, D., Enstrom, M., Radtke, S., Humbert, O., & Kiem, H. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.11.010 · Cited by 7
Letort, G., Duclert, A., Clerre, D. L., Chion-Sotinel, I., Salvatori, R., Dessez, E., Sevin, M., Rotondi, M. C., Ducani, C., Duchateau, P. N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66318-2 · Cited by 4
mGem: AAV, from almost a virus to an awesome vector—or is it?
Srivastava, A. (2026) · mBio · doi:10.1128/mbio.02957-25 · Cited by 5
Li, W., Wang, C., & Lu, Y. (2024) · Nano Research · doi:10.1007/s12274-024-6729-8 · Cited by 5
Synthetic mRNA for ex vivo therapeutic applications
Nakanishi, H., & Itaka, K. (2022) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2022.100447 · Cited by 4
Radtke, S., Pande, D., Cui, M., Perez, A. M., Chan, Y. Y., Enstrom, M., Schmuck, S., Berger, A., Eunson, T., Adair, J. E., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/850479 · Cited by 4
Somatic Genome Editing for Health: Disease Treatments and Beyond
Ishii, T. (2016) · Current Stem Cell Reports · doi:10.1007/s40778-016-0061-5 · Cited by 3
Targeted gene therapy into a safe harbor site in human hematopoietic progenitor cells
Rodríguez-Fornés, F., Bustamante, O. Q., Lozano, M. L., Segovia, J. C., Bueren, J. A., & Güenechea, G. (2020) · Gene Therapy · doi:10.1038/s41434-020-0144-x · Cited by 3
Recent applications of RNA therapeutic in clinics
Thi, H. T. H., & Than, V. T. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.12.015 · Cited by 3
Mechanisms for Controlling HIV-1 Infection: A Gene Therapy Approach
Ognenovska, K., Klemm, V., Ledger, S., Turville, S. G., Symonds, G. P., Kelleher, A. D., & Ahlenstiel, C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.79669 · Cited by 3
Guo, P., Yu, C., Wang, Q., Zhang, R., Meng, X., & Feng, Y. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.04.004 · Cited by 4
Genome engineering with Cas9 and AAV repair templates, successes and pitfalls
Birling, M., Hérault, Y., & Pavlovic, G. (2025) · Mammalian Genome · doi:10.1007/s00335-024-10099-4 · Cited by 3
Pervasive donor DNA integration defies precision gene editing of hematopoietic stem cells
Bauer, D. E. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.09.003 · Cited by 2
Patching up hematopoietic stem cells
Santilli, G., & Thrasher, A. J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3425 · Cited by 2
Gene Editing in Adult Hematopoietic Stem Cells
López-Manzaneda, S., Fañanas-Baquero, S., Nieto-Romero, V., Roman‐Rodriguez, F. J., Fernández-García, M., Pino-Barrio, M. J., Rodríguez-Fornés, F., Díez, B., García-Bravo, M., Navarro, S., et al. (2016) · InTech eBooks · doi:10.5772/62383 · Cited by 2
Electroporation by concentric-type needle electrodes and arrays
Kung, Y., Lihachev, A., Šatkauskas, S., Lan, K.-L., & Chen, W. (2017) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2017.06.014 · Cited by 2
FDA Gene Therapy Approvals (1998–2025): Current Status, Regulatory Evolution, and Future Directions
Oo, C., Qin, X., & Sy, S. K. B. (2026) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.70226 · Cited by 1
CRISPR/Cas jako inteligentny system immunologiczny bakterii i archea
Blicharska, D., Szućko-Kociuba, I., Filip, E., & Skuza, L. (2022) · Postępy Biochemii · doi:10.18388/pb.2021_453 · Cited by 1
Identification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
Radtke, S., & Kiem, H. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2679-5_6 · Cited by 1
Using Engineered Nucleases to Create HIV-Resistant Cells
Llewellyn, G. N., Exline, C. M., Holt, N. G., & Cannon, P. M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-3509-3_10 · Cited by 1
Self-citationHematopoietic stem cell gene therapy: progress and challenges
Zhang, X., Cheng, T., & Zhang, J. (2017) · Scientia Sinica Vitae · doi:10.1360/n052017-00268 · Cited by 1
Biomolecular Therapeutics for HIV
Li, S., & Burnett, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-50878-0.00018-5 · Cited by 1
Getting Past HSC Security: Cyclosporine H Gives Lentiviruses an Entry Pass
Bauer, D. E., & Pai, S. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.11.008 · Cited by 1
Genome editing in lysosomal disorders
Pimentel-Vera, L. N., Poletto, É., Gonzalez, E. A., Poswar, F. D. O., Giugliani, R., & Baldo, G. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.02.001 · Cited by 1
Stem Cell Engineering Developments And Advances In Providing HIV Immunity
DeSimone, J., & Gallicchio, V. S. (2021) · Journal Of Stem Cell Research · doi:10.52793/jscr.2021.2(2)-23
Letort, G., Duclert, A., Clerre, D. L., Chion-Sotinel, I., Salvatori, R., Dessez, E., Sevin, M., Rotondi, M. C., Ducani, C., Duchateau, P. N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.19.638978 · Cited by 1
Gomez‐Ospina, N., Vera, L. P., Gastou, M., Colella, P., Basurto, J. A., Feng, A., Lin, Y., Zhao, X., & Sun, Y. (2025) · Research Square · doi:10.21203/rs.3.rs-7123212/v1 · Cited by 1
A Tribute to George Stamatoyannopoulos
Srivastava, A., Kay, M. A., Athanasopoulos, T., Angastiniotis, M., Anagnostopoulos, Α., Karponi, G., Yannaki, E., Zon, L. I., Lederer, C. W., Phylactides, M., et al. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.29025.gst
Elucidation of Mechanisms of Fetal Hemoglobin Regulation by CRISPR/Cas9 Mediated Genome Editing
Canver, M. C. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Development of gene therapy using genome editing technology
Onodera, M. (2018) · Journal of Hematopoietic Cell Transplantation · doi:10.7889/hct-17-014
Therapeutic gene editing in hematopoietic progenitor cells from a mouse model of Fanconi anemiaPreprint
Pino-Barrio, M. J., Gimenez, Y. A., Villanueva, M., Hildenbeutel, M., Sánchez‐Domínguez, R., Rodríguez, S., Pujol, R. M., Surrallés, J., Rı́o, P., Cathomen, T., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/362251
Gene and Cell Therapy: Tearing Down Walls
VandenDriessche, T. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.29074.tva
Genome Editing Technologies: From Bench Side to Bedside
Tuncay, F. Y., & Dinçer, P. (2018) · Acta Medica · doi:10.32552/2018.actamedica.282
Reply to “Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors”
Rogers, G. L., Chen, H.-Y., Morales, H., & Cannon, P. M. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.11.003
Self-citationGene Editing Approaches for Haematological Disorders
Ferrari, S., & Canarutto, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00053-6
Engineered Cellular Immunotherapy for Cancer
Trivedi, N. H. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004201
Advances of Covalent Chemical Modifications of RNA
Li, Y., Cheng, K., Dong, P., Zhou, D., Tian, Y., Zou, J., Fan, J., & Zhao, Y. (2025) · Chemistry - A European Journal · doi:10.1002/chem.202502793
Bella, T. L. (2018) · theses.fr (ABES) · doi:10.70675/e88d9a08za929z4c0fzb8d9z9f01cd69ca39
CRISPR-Cas9-based strategies for enhanced targeted integration
Lacombe, L. (2024) · theses.fr (ABES) · doi:10.70675/9c9d279dz512az4b72z8322zea205cef9b67
Chen, H., Kadzioch, N. P., Gapp, M., Yang, H.-H., Ruhle, A., Villamizar, J. M., Fuchs, T., Schmacke, N. A., Hornung, V., Speck, R. F., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.05.741689
Metadata
- Authors
- Wang, J., Exline, C. M., DeClercq, J. J., Llewellyn, G. N., Hayward, S. B., Li, P. W.-L., Shivak, D. A., Surosky, R. T., Gregory, P. D., Holmes, M. C., & Cannon, P. M.
- Affiliations
- Sangamo BioSciences (United States) (US)
- University of Southern California (US)
- Corresponding author
- Holmes, Michael C
- Cannon, Paula M
- Venue
- Nature Biotechnology
- Published
- 2015-11-09
- Volume
- 33
- Issue
- 12
- Pages
- 1256-1263
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4842001
- OpenAlex
- W2230199130
- Semantic Scholar
- 53d1b136b5c5b110dfdadc143c98505fc8c15d6b
- Cited by
- 261
- References
- 68
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 13 · 2023: 15 · 2022: 20 · 2021: 26 · 2020: 24 · 2019: 31 · 2018: 35 · 2017: 39 · 2016: 41 · 2015: 2
- FWCI
- 16.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL073104, U19HL129902)
- National Institute of Dental and Craniofacial Research (R01DE025167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- hematopoietic stem and progenitor cells, homology-directed repair, zinc finger nucleases, AAV6 vector, mRNA electroporation, CCR5, AAVS1, long-term repopulating cells, fetal liver, peripheral blood stem cell mobilization, gene targeting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
